Literature DB >> 4112366

Alpha and beta adrenergic blockade in hypertension.

L J Beilin, B E Juel-Jensen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4112366     DOI: 10.1016/s0140-6736(72)91154-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  22 in total

1.  The effects of oral AH 5158, a combined α and β-adrenoceptor antagonist, in healthy volunteers.

Authors:  D A Richards; E P Woodings; M D Stephens; J G Maconochie
Journal:  Br J Clin Pharmacol       Date:  1974-12       Impact factor: 4.335

Review 2.  The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future.

Authors:  B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

3.  Clinical evaluation of indoramin, a new antihypertensive agent.

Authors:  P J Lewis; C F George; C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1973-12       Impact factor: 2.953

4.  Central alpha- and beta-adrenoceptors modifying arterial blood pressure and heart rate in conscious cats.

Authors:  M D Day; A G Roach
Journal:  Br J Pharmacol       Date:  1974-07       Impact factor: 8.739

5.  Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension.

Authors:  P A Majid; M K Meeran; M E Benaim; B Sharma; S H Taylor
Journal:  Br Heart J       Date:  1974-06

Review 6.  The management of hypertension.

Authors:  B N Prichard; C W Owens
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

7.  A comparison of labetalol and prazosin combined with atenolol in non-responders to atenolol plus hydrochlorothiazide in uncomplicated hypertension.

Authors:  E van der Veur; B S ten Berge; A J Donker; J F May; F H Schuurman; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  Comparison of labetalol, propranolol and hydralazine in hypertensive out-patients.

Authors:  E van der Veur; B S ten Berge; A J Donker; J F May; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

9.  Labetalol: potent antihypertensive agent that blocks both alpha- and beta-adrenergic receptors.

Authors:  B J Milne; A G Logan
Journal:  Can Med Assoc J       Date:  1980-11-22       Impact factor: 8.262

10.  Rate of onset of hypotensive effect of oral labetalol.

Authors:  M J Serlin; M C Orme; M Maciver; G J Green; C M Macnee; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.